Sol-Gel将向PellePharm支付470万美元的预付款,以及高达600万美元的开发和NDA验收里程碑,以及高达6400万美元的商业里程碑和分成。
Patidegib被Sol-Gel指定为SGT-610,用于治疗Go...查看全文
$Sol-Gel Technologies Ltd.(SLGL)$ F-1/A [Amend] - Registration statement for certain foreign private issuers Filed: 2018-01-30 AccNo: 0001144204-18-004431 Size: 4 MB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2018-01-26 AccNo: 0001144204-18-003836 Size: 20 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ CT ORDER - Confidential treatment order Filed: 2018-01-31 AccNo: 9999999997-18-000623 Size: 10 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ F-1/A [Amend] - Registration statement for certain foreign private issuers Filed: 2018-01-23 AccNo: 0001144204-18-003151 Size: 5 MB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ CERT [Paper] - Film#: 18562043 Filed: 2018-01-31 AccNo: 9999999997-18-000617 Size: 93 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ EFFECT - Notice of Effectiveness Filed: 2018-01-31 AccNo: 9999999995-18-000281 Size: 1 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ EFFECT - Notice of Effectiveness Filed: 2018-01-31 AccNo: 9999999995-18-000280 Size: 1 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2018-01-30 AccNo: 0001571049-18-000065 Size: 33 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ F-1/A [Amend] - Registration statement for certain foreign private issuers Filed: 2017-12-29 AccNo: 0001571049-17-008774 Size: 4 MB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2018-02-02 AccNo: 0001144204-18-005301 Size: 4 MB 网页链接